{"title": "Genetic and physical modification of human monocyte-derived dendritic cells in order to improve vaccination protocols", "author": "Knippertz; Ilka", "url": null, "hostname": null, "description": "Parts of the data were published in the \"Journal of Immunotherapy\" (2009 Jun;32(5):524-38), the \"International Journal of Hyperthermia\" (2011;27(6):591-603), and in \"Molecular and Cellular Biology\" (Epub ahead of print 2013 Jan 22). The discovery of tumor-associated antigens together with an improved insight into dendritic cell (DC) biology illustrating their key function in the immune system have provided a rationale to initiate DC-based cancer immunotherapy trials. Nevertheless, methods to generate tumor antigen-presenting DC and to improve their immunostimulatory function are continuously being optimized. Thus, in order to improve current anti-cancer vaccination protocols, human moDC were genetically and physically modified. In the first part of the thesis an adenoviral vector encoding human CD40L (Ad5hCD40L), was cloned and a new protocol for generating DC with the unique feature to migrate and to show prolonged secretion of the key cytokine IL-12p70 simultaneously in the presence of IFN-gamma and maturation cocktail (MC) has been established. Moreover, these modified DC were able to efficiently prime naive autologous CD8+ T cells into antigen-specific CTL. In the second part it was aimed to develop an adenoviral vector system using a mutated and constitutively active form of heat shock factor-1 (mHSF1), expressed under the control of the maturation specific CD83 promoter which then in turn will drive the heat shock element (HSE)-dependent expression of multiple immuno-regulatory genes and antigens. In this regard reporter gene assays, transgenic mice and a ChIP-Chip microarray were used to identify the regulatory element(s) within the CD83 gene. Results of the ChIP-analysis revealed a putative regulatory region within the first 6 kb of the intron 2, which will be further investigated in the future. Furthermore, a therapeutic replication-deficient Ad vector (Ad5-3xhsp70B), encoding three different HSE-driven transgene cassettes, was developed. Importantly, transduction of DC with Ad5-3xhsp70B in combination with Ad5mHSF1 revealed (i) a specific expression of transgenes such as MelanA, IL-12 and Bcl-xL under the control of mHSF1 and (ii) the utility of this vector system to prime antigen-specific T cell responses. Finally, DC were physically modified by exposure to mild thermal heat of 40\u00b0C for 24 hours, as mild elevations in temperature have been previously suggested to enhance immune activation. This work revealed for the first time that thermal stimulation of human moDC in vitro, which would be easily applicable in clinical settings, resulted in a strongly increased T cell stimulation. In summary, this thesis describes three different strategies to obtain DC with features that are of primary relevance to improve current clinical vaccination protocols for DC-mediated immunotherapy.", "sitename": "Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg (FAU)", "date": "2018-11-12", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Genetic and physical modification of human monocyte-derived dendritic cells in order to improve vaccination protocols\nGenetische und physikalische Modifizierung von monozyt\u00e4ren Dendritischen Zellen zur Verbesserung von Vakzinierungsprotokollen\nPlease always quote using this URN:\n[urn:nbn:de:bvb:29-opus-10161](https://nbn-resolving.org/urn:nbn:de:bvb:29-opus-10161)\n- <b>Parts of the data were published in the \"Journal of Immunotherapy\" (2009 Jun;32(5):524-38), the \"International Journal of Hyperthermia\" (2011;27(6):591-603), and in \"Molecular and Cellular Biology\" (Epub ahead of print 2013 Jan 22).</b> The discovery of tumor-associated antigens together with an improved insight into dendritic cell (DC) biology illustrating their key function in the immune system have provided a rationale to initiate DC-based cancer immunotherapy trials. Nevertheless, methods to generate tumor antigen-presenting DC and to improve their immunostimulatory function are continuously being optimized. Thus, in order to improve current anti-cancer vaccination protocols, human<b>Parts of the data were published in the \"Journal of Immunotherapy\" (2009 Jun;32(5):524-38), the \"International Journal of Hyperthermia\" (2011;27(6):591-603), and in \"Molecular and Cellular Biology\" (Epub ahead of print 2013 Jan 22).</b> The discovery of tumor-associated antigens together with an improved insight into dendritic cell (DC) biology illustrating their key function in the immune system have provided a rationale to initiate DC-based cancer immunotherapy trials. Nevertheless, methods to generate tumor antigen-presenting DC and to improve their immunostimulatory function are continuously being optimized. Thus, in order to improve current anti-cancer vaccination protocols, human moDC were genetically and physically modified. In the first part of the thesis an adenoviral vector encoding human CD40L (Ad5hCD40L), was cloned and a new protocol for generating DC with the unique feature to migrate and to show prolonged secretion of the key cytokine IL-12p70 simultaneously in the presence of IFN-gamma and maturation cocktail (MC) has been established. Moreover, these modified DC were able to efficiently prime naive autologous CD8+ T cells into antigen-specific CTL. In the second part it was aimed to develop an adenoviral vector system using a mutated and constitutively active form of heat shock factor-1 (mHSF1), expressed under the control of the maturation specific CD83 promoter which then in turn will drive the heat shock element (HSE)-dependent expression of multiple immuno-regulatory genes and antigens. In this regard reporter gene assays, transgenic mice and a ChIP-Chip microarray were used to identify the regulatory element(s) within the CD83 gene. Results of the ChIP-analysis revealed a putative regulatory region within the first 6 kb of the intron 2, which will be further investigated in the future. Furthermore, a therapeutic replication-deficient Ad vector (Ad5-3xhsp70B), encoding three different HSE-driven transgene cassettes, was developed. Importantly, transduction of DC with Ad5-3xhsp70B in combination with Ad5mHSF1 revealed (i) a specific expression of transgenes such as MelanA, IL-12 and Bcl-xL under the control of mHSF1 and (ii) the utility of this vector system to prime antigen-specific T cell responses. Finally, DC were physically modified by exposure to mild thermal heat of 40\u00b0C for 24 hours, as mild elevations in temperature have been previously suggested to enhance immune activation. This work revealed for the first time that thermal stimulation of human moDC in vitro, which would be easily applicable in clinical settings, resulted in a strongly increased T cell stimulation. In summary, this thesis describes three different strategies to obtain DC with features that are of primary relevance to improve current clinical vaccination protocols for DC-mediated immunotherapy.\u2026\n- <b>Parts of the data were published in the \"Journal of Immunotherapy\" (2009 Jun;32(5):524-38), the \"International Journal of Hyperthermia\" (2011;27(6):591-603), and in \"Molecular and Cellular Biology\" (Epub ahead of print 2013 Jan 22).</b> Die Entdeckung der tumor-assoziierten Antigene, sowie der wachsende Kenntnisstand \u00fcber die Bedeutung der dendritischen Zelle (DZ) f\u00fcr das Immunsystem, bildeten die Grundlage f\u00fcr den Beginn von auf DZ-basierenden immunotherapeutischen Studien in der Krebstherapie. Dennoch besteht weiterhin die Notwendigkeit, sowohl die Methoden zur Generierung von antigen-pr\u00e4sentierenden dendritischen Zellen als auch ihre immunstimulatorische F\u00e4higkeit zu verbessern. Daher<b>Parts of the data were published in the \"Journal of Immunotherapy\" (2009 Jun;32(5):524-38), the \"International Journal of Hyperthermia\" (2011;27(6):591-603), and in \"Molecular and Cellular Biology\" (Epub ahead of print 2013 Jan 22).</b> Die Entdeckung der tumor-assoziierten Antigene, sowie der wachsende Kenntnisstand \u00fcber die Bedeutung der dendritischen Zelle (DZ) f\u00fcr das Immunsystem, bildeten die Grundlage f\u00fcr den Beginn von auf DZ-basierenden immunotherapeutischen Studien in der Krebstherapie. Dennoch besteht weiterhin die Notwendigkeit, sowohl die Methoden zur Generierung von antigen-pr\u00e4sentierenden dendritischen Zellen als auch ihre immunstimulatorische F\u00e4higkeit zu verbessern. Daher wurden im Rahmen dieser Arbeit Strategien zur genetischen und physikalischen Modifikation von DZ entwickelt, die die gegenw\u00e4rtigen Vakzinierungsprotokolle in der Krebstherapie verbessern sollen. Im ersten Abschnitt dieser Arbeit wurde deshalb ein Adenovirus (Ad5hCD40L) generiert, welches f\u00fcr das humane CD40L-Protein kodiert und mit dessen Hilfe eine einzigartige DZ generiert werden konnte, die in Anwesenheit von IFN-gamma und des Reifungscocktails sowohl migratorische F\u00e4higkeiten besitzt, als auch das \u00fcberaus wichtige Zytokin IL-12p70 produziert. Weiterhin konnte gezeigt werden, dass so modifizierte DZ sehr effizient in der Stimulation von naiven autologen CD8+ T Zellen sind. Im zweiten Abschnitt dieser Arbeit sollte ein adenovirales Vektorsystem entwickelt werden, bei welchem die von einem reifungs-spezifischem CD83-Promotor kontrollierte Expression eines mutierten und konstitutiv aktiven Hitzeschock-Faktors 1 (mHSF1) die Hitzeschock-Element (HSE) -abh\u00e4ngige Expression verschiedener immunregulatorischer Gene und Antigene steuern soll. In diesem Zusammenhang wurden so genannte \u201ereporter\u201c-Genanalysen, BAC-transgene M\u00e4use und eine ChIP-Chip Analyse eingesetzt, um weitere regulatorische Elemente im CD83 Gen zu identifizieren. Ergebnisse der ChIP-Analyse ergaben ein potenzielles regulatorisches Element innerhalb der ersten 6 kb des Intron 2, was in zuk\u00fcnftigen Arbeiten weiter untersucht werden wird. Dar\u00fcber hinaus wurde ein replikationsdefizientes Adenovirus (Ad5-3xhsp70B) entwickelt, welches f\u00fcr drei verschiedene HSE-getriebene Transgen-Kassetten kodiert. Die Transduktion von DZ mit Ad5-3xhsp70B ergab hierbei (1) eine spezifische Expression der Transgene MelanA, IL-12 und Bcl-xL unter der Kontrolle des mHSF1 sowie (2) eine Induzierbarkeit von antigen-spezifischen T Zell-Antworten. Im dritten Abschnitt dieser Arbeit wurden DZ mittels einer Temperaturerh\u00f6hung auf 40\u00b0C f\u00fcr 24 Stunden physikalisch modifiziert, da zuvor bekannt war, dass dieser leichte Temperaturanstieg eine Aktivierung des Immunsystems zur Folge haben kann. Bez\u00fcglich dessen konnte im Rahmen dieser Arbeit zum ersten Mal gezeigt werden, dass die thermale Stimulation humaner DZ in vitro, die in klinischen Anwendungen einfach umzusetzen w\u00e4re, eine deutliche Erh\u00f6hung der T Zell-stimulatorische F\u00e4higkeit der DZ zur Folge hat. Zusammenfassend beschreibt diese Dissertation drei verschiedene Strategien der Modifikation von DZ zur Verbesserung von Vakzinierungsprotokollen f\u00fcr die DZ-vermittelte Immuntherapie in der klinischen Forschung.\u2026\n|Author:|[urn:nbn:de:bvb:29-opus-10161](https://nbn-resolving.org/urn:nbn:de:bvb:29-opus-10161)\nCancer immunotherapy; Dendritic cell; Vaccination", "language": null, "image": null, "pagetype": null, "links": ["/opus4-fau/home/index/language/language/de/rmodule/frontdoor/rcontroller/index/raction/index/docId/680", "/opus4-fau/auth/login/docId/680/rmodule/frontdoor/rcontroller/index/raction/index", "http://www.ub.fau.de/", "/opus4-fau/home", "/opus4-fau/solrsearch", "/opus4-fau/solrsearch/browse", "/opus4-fau/publish", "/opus4-fau/home/index/help", "javascript:void(0)", "https://nbn-resolving.org/urn:nbn:de:bvb:29-opus-10161", "/opus4-fau/solrsearch/index/search/searchtype/authorsearch/author/Ilka+Knippertz", "/opus4-fau/files/680/IlkaKnippertzDissertation.pdf", "/opus4-fau/citationExport/index/download/docId/680/output/bibtex", "/opus4-fau/citationExport/index/download/docId/680/output/ris", "http://twitter.com/share?url=https://opus4.kobv.de/opus4-fau/frontdoor/index/index/docId/680", "http://scholar.google.de/scholar?hl=en&q=\"Genetic and physical modification of human monocyte-derived dendritic cells in order to improve vaccination protocols\"&as_sauthors=Ilka+Knippertz&as_ylo=2008&as_yhi=2008", "javascript:void(0)", "/opus4-fau/solrsearch/index/search/searchtype/authorsearch/author/Ilka+Knippertz", "https://nbn-resolving.org/urn:nbn:de:bvb:29-opus-10161", "/opus4-fau/solrsearch/index/search/searchtype/collection/id/16248", "/opus4-fau/solrsearch/index/search/searchtype/collection/id/614", "/opus4-fau/solrsearch/index/search/searchtype/collection/id/16201", "https://dini.de/dienste-projekte/dini-zertifikat/", "https://dini.de/dienste-projekte/dini-zertifikat/", "https://www.coar-repositories.org/community/members-and-partners-by-country/", "http://www.kobv.de/opus4/", "/opus4-fau/home/index/contact", "/opus4-fau/home/index/imprint", "https://opus4.kobv.de/opus4-fau/home/index/help#disclaimer", "/opus4-fau/crawlers/sitelinks", "#", "https://opus4.kobv.de/opus4-fau/home/index/help#disclaimer"]}